Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Cannon RE, Peart JC, Hawkins BT, Campos CR, Miller DS Proc Natl Acad Sci U S A. 2012 Sep 4. PMID: 22949658. Abstract CommentRecommendBookmarkWatch